ROCHESTER, N.Y., Oct. 16 /PRNewswire/ -- Many routine surgical biopsies could become a thing of the past as dermatologists may soon be sharing, reviewing and diagnosing noninvasive digital images of skin cells via the Internet, using Lucid Inc.'s VivaNet(TM) telemedicine server and its VivaScope(R) confocal imagers.
The technology, which relies on using special microscopes to digitally image a patient's skin, may bypass the need to surgically biopsy many patients. "VivaScope imaging sessions require only 5 to 10 minutes of a physician's assistant's time," said Jay Eastman, Ph.D., CEO, Lucid Inc. (http://www.lucid-tech.com).
The cellular resolution images may then be used by physicians to assist in forming a clinical judgment for a variety of skin conditions, including, for example, melanoma, basal cell carcinoma, actinic keratoses, and contact dermatitis.
A typical VivaScope imaging session produces two types of images of the patient's skin: dermatoscopic-quality, full-color macroscopic pictures, and microscopic, cellular resolution images. Like a routine biopsy, the images can then be read by a dermatologist or a pathologist and the diagnosis presented to the patient.
"Just as MRI and CT scans have largely eliminated the need for routine exploratory surgery, in-vivo confocal imaging may one day eliminate the need for routine invasive skin biopsy," Eastman stated.
Improving Quality of Life for Dermatology Patients
Already, dozens of Lucid's VivaScopes are in regular use throughout the
U.S. and Europe. "Lucid's VivaScope(R) 1500 has the capability of imaging
virtually all types of skin cancers, which makes it useful for many
everyday procedures in a dermatology practice," stated Dr. Harold
Rabinovitz, a Florida based dermatologist who specializes in skin cancer.
"The VivaScope is an incredible diagnostic tool and now routinely aids me
in the clinical evaluation of potenti
|SOURCE Lucid Inc.|
Copyright©2007 PR Newswire.
All rights reserved